|
Market Closed -
Nasdaq
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.390 USD | -1.60% |
|
-2.89% | +85.68% |
| Market Cap | 11Cr 9.84Cr 9.18Cr 8.37Cr 16Cr 1.06TCr 16Cr 111.12Cr 43Cr 544.15Cr 42Cr 41Cr 1.75TCr | P/E 2024 |
-5.14x | P/E 2025 | -20.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11Cr 9.73Cr 9.08Cr 8.27Cr 16Cr 1.05TCr 16Cr 109.85Cr 43Cr 537.94Cr 41Cr 40Cr 1.73TCr | EV / Sales 2024 |
0.95x | EV / Sales 2025 | 1.31x |
| Free-Float |
57.75% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CPIX | Delayed | |
CBOE
| CPIX | Real-time |
Last Transcript: Cumberland Pharmaceuticals Inc.
| 1 day | -1.60% | ||
| 1 week | -2.89% | ||
| Current month | -5.62% | ||
| 1 month | +8.84% | ||
| 3 months | +16.01% | ||
| 6 months | +133.12% | ||
| Current year | +85.68% |
| 1 week | 7.26 |  | 8.14 |
| 1 month | 6.24 | | 8.35 |
| Current year | 2.69 | | 9.28 |
| 1 year | 1.85 | | 9.28 |
| 3 years | 1.04 | | 9.28 |
| 5 years | 1.04 | | 9.28 |
| 10 years | 0 | | 9.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CEO | Chief Executive Officer | 67 | 07/01/1999 |
John Hamm
DFI | Director of Finance/CFO | 70 | 17/05/2021 |
Shayla Simpson
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
A. Kazimi
CHM | Chairman | 67 | 07/01/1999 |
Gordon Bernard
BRD | Director/Board Member | 74 | 10/09/2010 |
James Jones
BRD | Director/Board Member | 78 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Free | Executive/Senior Manager | 3,000 | 0.0201% | ||
| 18/03/26 | Free | Director | 5,800 | 0.0388% | ||
| 18/03/26 | Free | Director | 1,800 | 0.0120% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.60% | -2.89% | +136.10% | +295.19% | 11Cr | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,01900Cr | |
| -1.02% | -5.60% | +35.72% | +64.63% | 62TCr | |
| +1.11% | -0.58% | +12.36% | +77.95% | 46TCr | |
| +0.34% | -3.01% | +61.79% | +41.24% | 36TCr | |
| +1.49% | -1.07% | +21.91% | +42.52% | 33TCr | |
| +1.35% | -2.73% | +11.61% | +35.37% | 27TCr | |
| +0.64% | -4.23% | -5.99% | +9.74% | 24TCr | |
| -1.04% | -2.79% | +35.30% | +51.84% | 22TCr | |
| -1.87% | -4.10% | +28.44% | +93.66% | 18TCr | |
| Average | -0.05% | -3.48% | +37.33% | +82.72% | 36.97TCr | |
| Weighted average by Cap. | +0.12% | -3.54% | +29.29% | +70.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 3.79Cr 3.36Cr 3.14Cr 2.86Cr 5.4Cr 364.04Cr 5.45Cr 38Cr 15Cr 186.1Cr 14Cr 14Cr 597.26Cr | 4.45Cr 3.96Cr 3.69Cr 3.37Cr 6.35Cr 428Cr 6.41Cr 45Cr 17Cr 218.8Cr 17Cr 16Cr 702.2Cr |
| Net income | -64.8L -57.57L -53.73L -48.98L -92.37L -62Cr -93.23L -6.5Cr -2.52Cr -32Cr -2.43Cr -2.38Cr -102.2Cr | -28.36L -25.2L -23.52L -21.44L -40.43L -27Cr -40.81L -2.85Cr -1.1Cr -14Cr -1.06Cr -1.04Cr -45Cr |
| Net Debt | 26.08L 23.17L 21.63L 19.71L 37.18L 25Cr 37.53L 2.62Cr 1.01Cr 13Cr 97.93L 95.8L 41Cr | -12.64L -11.23L -10.48L -10L -18.02L -12Cr -18.19L -1.27Cr -49.16L -6.21Cr -47.47L -46.43L -20Cr |
Employees
88
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $7.390 | -1.60% | 22,629 |
| 01/26/01 | $7.510 | -4.09% | 73,339 |
| 30/26/30 | $7.830 | +2.35% | 9,962 |
| 29/26/29 | $7.650 | -0.91% | 8,930 |
| 28/26/28 | $7.720 | +1.45% | 30,313 |
- Stock Market
- Stocks
- CPIX Stock
Select your edition
All financial news and data tailored to specific country editions
